Kura Oncology to Present at TD Cowen 7th Annual Oncology Innovation Summit

Kura Oncology (Nasdaq: KURA) will participate in the TD Cowen 7th Annual Oncology Innovation Summit on May 26, 2026.

Rhea-AI Summary

Kura Oncology (Nasdaq: KURA) will participate in the TD Cowen 7th Annual Oncology Innovation Summit on May 26, 2026. Management will join a virtual fireside chat at 1:30 p.m. ET / 10:30 a.m. PT, with live and archived webcasts available via the company’s investor website.

Argus May 20 session

+15.40% close to close Open Argus

Details

News Market Reaction – KURA

In the May 20 session, KURA gained 15.40%, reflecting a significant positive market reaction.

Data tracked by StockTitan Argus on the day of publication.

Market Context

The stock surged +15.4% in the session following this news. A strong positive reaction aligns with K...

Analysis

The stock surged +15.4% in the session following this news. A strong positive reaction aligns with Kura Oncology’s pattern of favorable responses to conference and data-related communications, as seen around prior events in early May 2026. However, past moves have occasionally reversed after equity-related developments or earnings. Investors would need to monitor upcoming presentations, commercialization progress for KOMZIFTI, and any new corporate filings for signs that enthusiasm could cool or be reinforced.

Key Figures

Fireside chat time: 1:30 p.m. ET / 10:30 a.m. PT

Fireside chat time

1:30 p.m. ET / 10:30 a.m. PT

TD Cowen 7th Annual Oncology Innovation Summit on May 26, 2026

Historical Context

5 past events · Latest: May 12

5 events

1. May 12

   Q1 2026 earnings

   24h Move

   -2.1%

   First commercial-stage quarter with KOMZIFTI revenue and higher operating expenses.

2. May 12

   Clinical data update

   24h Move

   +1.8%

   Strong KOMET-007 frontline AML data presented ahead of EHA 2026 Congress.

3. May 06

   Conference participation

   24h Move

   +2.9%

   Participation in Bank of America Healthcare Conference fireside chat webcast.

4. May 05

   Earnings date notice

   24h Move

   +0.4%

   Announcement of timing for Q1 2026 results and corporate update call.

5. May 04

   Equity inducement grants

   24h Move

   +5.5%

   Inducement stock option grants for new employees under 2023 Inducement Plan.

24h Move is the share-price change in the day after each event; other market factors may also have contributed.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

SAN DIEGO, May 19, 2026 (GLOBE NEWSWIRE) -- Kura Oncology, Inc. (Nasdaq: KURA) today announced its participation in the TD Cowen 7^th Annual Oncology Innovation Summit: Insights for ASCO & EHA. Kura management is scheduled to participate in a virtual fireside chat at 1:30 p.m. ET / 10:30 a.m. PT on May 26, 2026.

The live webcast and archived replay of the event may be accessed on the Investors section of the Company’s website at www.kuraoncology.com.

About Kura Oncology

Kura Oncology is a biopharmaceutical company committed to realizing the promise of precision medicines for the treatment of cancer. Kura’s pipeline of small molecule drug candidates is designed to target cancer signaling pathways and address high-need hematologic malignancies and solid tumors. Kura developed and is commercializing KOMZIFTI™ (ziftomenib), the FDA-approved once-daily, oral menin inhibitor for the treatment of adults with relapsed or refractory NPM1-mutated acute myeloid leukemia, and continues to pioneer advancements in menin inhibition and farnesyl transferase inhibition. For additional information, please visit the Kura website at https://kuraoncology.com/ and follow us on X and LinkedIn.

Kura Contact

Greg Mann (Investors and Media)
858-987-4046
gmann@kuraoncology.com

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

When will Kura Oncology (KURA) present at the TD Cowen 7th Annual Oncology Innovation Summit?

Kura Oncology will present on May 26, 2026, in a virtual fireside chat. According to Kura Oncology, the session is scheduled for 1:30 p.m. ET / 10:30 a.m. PT as part of the TD Cowen Oncology Innovation Summit.

What is the format of Kura Oncology’s presentation at the TD Cowen Oncology Innovation Summit 2026?

Kura Oncology will participate in a virtual fireside chat at the summit. According to Kura Oncology, company management will discuss its business in an online session, accessible through a live webcast and later as an archived replay.

How can investors watch Kura Oncology’s TD Cowen Oncology Innovation Summit webcast?

Investors can access Kura Oncology’s webcast through the Investors section of its website. According to Kura Oncology, both the live virtual fireside chat and an archived replay will be available at www.kuraoncology.com for those unable to attend live.

Will a replay of Kura Oncology’s May 26, 2026 TD Cowen summit presentation be available?

Yes, an archived replay of Kura Oncology’s presentation will be available after the event. According to Kura Oncology, investors can find the replay in the Investors section of the company’s website, alongside the live webcast link.

What time is Kura Oncology’s virtual fireside chat at the TD Cowen Oncology Innovation Summit?

Kura Oncology’s fireside chat is scheduled for 1:30 p.m. ET / 10:30 a.m. PT. According to Kura Oncology, this session is part of the TD Cowen 7th Annual Oncology Innovation Summit focused on oncology insights.